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SUMMARY – The aim of this study was to evaluate complete blood cell count parameters includ-
ing red blood cell indices, white blood cell subtypes, and platelet indices for predicting deep vein 
thrombosis (DVT). A total of 71 (44 male and 27 female) patients with acute femoral and popliteal 
DVT diagnosed by doppler ultrasonography during a period of seven years (2011-2017) were in-
cluded in the study. By matching age and gender, 142 (88 male and 54 female) subjects diagnosed with 
venous insufficiency in the same time interval were assigned as control group. Data were obtained by 
reviewing hospital records of the study participants, including clinical and demographic characteristics 
and complete blood cell parameters. Frequencies of hypertension, diabetes mellitus, chronic obstruc-
tive pulmonary disease, chronic renal failure, and coronary arterial disease were higher in DVT group 
as compared to non-DVT group (p<0.05). Hemoglobin and lymphocyte values were lower, and red 
blood cell distribution width, neutrophil, neutrophil to lymphocyte ratio, and platelet to lymphocyte 
ratio higher in DVT group as compared with non-DVT group (p<0.05). There was no significant 
between-group difference in terms of mean corpuscular volume, platelet, mean platelet volume, mean 
platelet volume to platelet ratio, and platelet distribution width (p>0.05). Hypertension, hemoglobin, 
neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio were independent risk factors for 
DVT. We found that hypertension, anemia, neutrophil to lymphocyte ratio, and platelet to lympho-
cyte ratio were independent risk factors for DVT. In particular, neutrophil to lymphocyte ratio and 
hemoglobin may be used as novel, inexpensive, and reliable diagnostic tools for DVT.
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Introduction
Deep vein thrombosis (DVT) is a cardiovascular 
disease that occurs when a blood clot forms in deep 
veins, usually in legs1. DVT has an incidence of ap-
proximately 1.6:1000 per year2. There are three main 
risk factors for DVT, i.e. hypercoagulability, venous 
stasis, and vascular injury3. Fine-tuning between pro-
coagulant and anticoagulant factors is indispensable to 
prevent clotting of blood in vessels3. Venous stasis as-
sociated with prolonged seated immobility, such as 
long-distance travels, computer usage, or medical im-
mobility including bed-rest and wheelchair usage is 
another important risk factor for DVT4,5. A variety of 
vascular injuries including extremity trauma related to 
repetitive motion or high-speed collisions are among 
causes of DVT6,7.
Recently, complete blood cell count (CBC) param-
eters as inexpensive and practical laboratory tests have 
become an interesting research area because of their 
potential benefits with regard to screening, prediction, 
classification, prognosis, and treatment monitoring of 
cardiovascular diseases8-11.
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A great number of patients with DVT can develop 
post-thrombotic syndrome and pulmonary embolism 
that may cause major health and economic problems, 
particularly if no early treatment is achieved12,13. For 
this reason, early diagnosis and treatment is essential 
to prevent the complications of DVT, and in this way 
to minimize morbidity and mortality and reduce 
health care costs.
The aim of this study was to evaluate CBC param-
eters including red blood cell (RBC) indices, white 
blood cell (WBC) subtypes, and platelet indices for 
predicting DVT.
Patients and Methods
This study was approved by the Ethics Committee 
of our Faculty of Medicine. A total of 71 (44 male and 
27 female) patients with acute femoral and popliteal 
DVT diagnosed by doppler ultrasonography during a 
period of seven years (2011-2017) were included in 
the study. The patients were aged 20-89 years. Exclu-
sion criteria were as follows: active cancer, surgical op-
eration within two months, acute trauma, immobility, 
autoimmune diseases, and pregnancy. By matching age 
and gender, 142 (88 male and 54 female) subjects di-
agnosed with venous insufficiency in the same time 
interval were assigned as control group. Data were ob-
tained by reviewing hospital records of the partici-
pants, including clinical and demographic characteris-
tics and CBC parameters (hemoglobin levels, hemato-
crit, mean corpuscular volume (MCV), RBC distribu-
tion width (RDW), WBC counts, platelet count, mean 
platelet volume (MPV), and platelet distribution 
width (PDW)) measured on an ABX Pentra DX 120 
(HORIBA, France) hematology analyzer. Hemato-
logic values in the records were assayed from venous 





Age (yrs) 55.14±17.42 54.19±15.64 0.0698
Gender:
 female, n (%) 27 (38.0) 54 (38.0) 1.000
 male, n (%) 44 (62.0) 88(62.0) 1.000
Hypertension, n (%) 21 (29.6) 5 (3.5) 0.000
Diabetes mellitus, n (%) 7 (9.9) 1 (0.7) 0.001
COPD, n (%) 8 (11.3) 1 (0.7) 0.000
SVD, n (%) 2 (2.8) 0 (0.0) 0.133
CRF, n (%) 6 (8.5) 0 (0.0) 0.000
CAD,n (%) 4 (5.6) 1 (0.7) 0.025
Hb (g/dL) 12.89±2.13 14.80±1.34 0.000
MCV(fL) 83.5±7.81 85.60±5.94 0.087
RDW (%) 14.00±4.60 11.77±5.00 0.006
Neutrophil (109/L) 5.72±2.31 3.88±1.09 0.000
Lymphocyte (109/L) 1.71±0.59 1.71±0.59 0.000
NLR 3.99±3.24 1.92±0.73 0.000
Plt (109/L) 240.71±9.07 243.08±69.60 0.850
PLR median
(%25-75 percentile) 133.42(98.33-187.53) 110.19(89.80-144.00) 0.010
MPV(fL) 9.78±1.77 9.79±1.43 0.952
MPV/platelet (fL) 0.05±0.02 0.04±0.01 0.313
PDW(fL) 12.70±2.88 13.19±2.69 0.295
DVT = deep vein thrombosis; DM = diabetes mellitus; HT = hypertension; COPD = chronic obstructive pulmonary 
disease; SVD = cerebrovascular disease; CRF = chronic renal failure; CAD = coronary artery disease; Hb = hemoglo-
bin; MCV = mean corpuscular volume; RDW = red cell distribution width; NLR = neutrophil to lymphocyte ratio; 
Plt = platelet; PLR = platelet to lymphocyte ratio; MPV = mean platelet volume; PDW = platelet distribution width
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blood samples taken simultaneously with the diagnosis 
of acute DVT. In addition, neutrophil-to-lymphocyte 
ratio (NLR), platelet-to-lymphocyte ratio (PLR), and 
MPV-to-platelet ratio were calculated.
The research procedures were performed according 
to the regulations of the institutional Ethics Commit-
tee and the Code of Ethics of the World Medical As-
sociation (Declaration of Helsinki).
Statistical analyses
Data were analyzed by using SPSS software ver-
sion 20.0 (IBM, USA). In descriptive statistics, con-
tinuous variables were expressed as mean ± standard 
deviation (SD) and median (0.25-0.75 percentile), and 
categorical variables as frequency (n) and percentage 
(%). The participants were divided into two groups 
with and without DVT. The normality of distribution 
was assessed by Kolmogorov-Smirnov test. For nu-
merical variables, differences between patients and 
controls were tested using Student’s t-test for para-
metric data or Mann-Whitney U test for non-para-
metric data. Categorical variables were analyzed using 
Pearson χ2-test and Fisher exact test for parametric 
and non-parametric data, respectively. To identify the 
independent predictors of DVT, parameters that were 
significant in univariate analysis were included in mul-
tivariate logistic regression analysis.
Receiver operating characteristic (ROC) curve 
analysis was used to identify the optimal cut-off values 
and to compare predictive values for diagnosis of DVT 
of parameters that were significant in multivariate 
analysis. The significance of difference between the ar-
eas under ROC curves (AUCs) was tested by using the 
method of DeLong et al.14 to compare performances 
of predictors of DVT. The level of statistical signifi-
cance was set at p<0.05.
Results
Demographic and laboratory data of patients with 
and without DVT are shown in Table 1. There was no 
difference between the groups in age and gender dis-
tribution (p>0.05). The frequencies of hypertension 
(HT), diabetes mellitus (DM), chronic obstructive 
pulmonary disease (COPD), chronic renal failure 
(CRF), and coronary arterial disease (CAD) were 
higher in DVT group as compared with non-DVT 
group (p<0.05). Hemoglobin (Hb) and lymphocyte 
values were lower, and RDW, neutrophil, NLR and 
PLR higher in DVT group as compared with non-
DVT group (p<0.05). There was no significant be-
Table 2.Univariate and multivariate regression analyses for DVT
Variable
Univariate analysis Multivariate analysis
Odds ratio 95% CI p value Odds ratio 95% CI p value
HT 7.975 1.334-47.684 0.023 8.005 1.417-45.220 0.019
Hb 0.462 0.310-0.689 0.000 0.490 0.348-0.692 0.000
NLR 4.214 2.269-7.827 0.000 4.484 2.453-8.195 0.000
PLR 0.988 0.975-1.000 0.048 0.987 0.975-0.999 0.028
DVT = deep vein thrombosis; CI = confidence interval; HT = hypertension; Hb = hemoglobin; NLR = neutrophil to lymphocyte ratio; 
PLR = platelet to lymphocyte ratio
Fig. 1. Comparison of areas under ROC curves (AUCs) 
for hemoglobin (Hb), neutrophil to lymphocyte ratio 
(NLR), and platelet to lymphocyte ratio (PLR)  
in predicting deep vein thrombosis.
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tween-group difference according to MCV, PLT, 
MPV, MPV:platelet ratio, and PDW (p>0.05).
Demographic and laboratory parameters (HT, 
DM, COPD, CRF, CAD, Hb, RDW, neutrophil 
count, lymphocyte count, NLR, and PLR) found to be 
significant in univariate analysis were then included in 
multivariate analysis. HT, Hb, NLR, and PLR were 
identified as independent risk factors for DVT. Results 
of univariate and multivariate analyses are depicted in 
Table 2.
Additionally, statistical comparisons were made for 
the AUCs of the parameters found to be independent 
predictors for DVT in multivariate analysis (Fig. 1). 
The AUCs for NLR, PLR, and Hb were 0.814 (95% 
CI: 0.744-0.884, p<0.001), 0.621 (95% CI: 0.529-
0.714, p=0.028), and 0.765 (95% CI: 0.683-0.848, 
p<0.001), respectively. AUC values of NLR and Hb 
were similar to each other (p=0.3875) and higher than 
that of PLR (p=0.0002 and p=0.0074, respectively). 
The sensitivity and specificity for NLR of >1.9657 
were 88.5% and 60.6%; for PLR of >170.5393 34.6% 
and 87.3%; and for Hb of <13.3 g/dL 57.69% and 
86.62%, respectively.
Discussion
In our study, hypertension was observed in 29.6% 
of DVT patients and was found to be an independent 
risk factor for DVT. In a comprehensive study includ-
ing 5063 patients with DVT, Sun et al.15 report that 
55.56% of patients had hypertension. Similarly, Li et 
al.16 and Guo et al.17 found the frequency of hyperten-
sion in patients with DVT to be 51.9% (27/52) and 
50.8% (31/61), respectively. However, there are a few 
studies that declare that there is no significant correla-
tion of hypertension with DVT18,19. Also, in the study 
by Ren et al.20, hypertension was not a risk factor for 
DVT relapse. It is well known that hypertension may 
lead to vascular endothelium dysfunction and hyper-
coagulable state, and is one of the major risk factors for 
cardiovascular diseases21-23. Our results agree with the 
majority of studies on the association between DVT 
and hypertension, and may be interpreted as showing 
that hypertension made these individuals more sus-
ceptible to coagulation.
We found that anemia was an independent risk 
factor for DVT, which is compatible with previous 
studies suggesting that anemia is associated with DVT 
and other cardiovascular disorders24,25. This finding 
may be explained by two scenarios, i.e. underlying 
common etiologic causes related to both anemia and 
DVT, and adverse effects related to anemia, such as 
endothelial dysfunction, hypercoagulable state, and 
blood stasis24. There was a limitation to our study be-
cause anemia was not classified. Another study may be 
designed to determine association between DVT and 
factors leading to anemia.
It has been demonstrated that there is close asso-
ciation between inflammation and thrombosis26-28. In-
flammation shows thrombotic effect by stimulating 
procoagulant factors and platelet reactivity and by in-
hibiting anticoagulants and fibrinolytic activity26,29. 
Extracellular chromatin originating from neutrophils 
has been reported to be prothrombotic30. These find-
ings may explain why we found NLR as an indepen-
dent risk factor for DVT. In a previous study, it was 
suggested that NLR may be useful in determining the 
extent of venous thromboembolism31. However, Rou-
men-Klappe et al.32 asserted that increased inflamma-
tory markers in DVT might be a result rather than a 
cause of the disease.
It has been established that PLR is associated with 
arterial thrombosis and various cancers; however, its role 
in DVT has not been fully elucidated33,34. In our study, 
PLR was higher in patients with DVT compared to 
controls. Increased PLR, high platelet counts relative to 
lymphocyte counts, may indicate elevated predisposi-
tion to clot formation33. Recently, Mouabbi et al.35 have 
put forward that PLR is superior to D-dimer, increasing 
classically in clot situations, in terms of predicting the 
absence or presence of DVT. In the study by Ming et 
al.9, although it was found that PLR had diagnostic 
value in unprovoked DVT, it was not an independent 
risk factor for DVT. In another study, increased PLR 
was not associated with the risk of venous thromboem-
bolism or cerebral vein thrombosis, but it was associated 
with thrombophilia abnormalities in cerebral vein 
thrombosis36. However, in our study, since we excluded 
patients with thrombophilia abnormalities, we may say 
that elevated PLR could have a predictive value in DVT 
independent of thrombophilia abnormalities.
In conclusion, we found that HT, anemia, NLR, and 
PLR were independent risk factors for DVT. Especially 
NLR and Hb may be used as novel, inexpensive, and 
reliable diagnostic tools for DVT. Nonetheless, these 
findings must be supported by further studies.
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Sažetak
MOGU LI PARAMETRI KOMPLETNE KRVNE SLIKE PREDVIDJETI  
DUBOKU VENSKU TROMBOZU?
K. Tural, F. Kara, S. Avcı i H.İ. Erdoğdu
Cilj ovoga istraživanja bio je procijeniti parametre kompletne krvne slike (KKS) uključujući eritrocitne indekse, podvrste 
leukocita i trombocitne pokazatelje za predviđanje duboke venske tromboze (DVT). U istraživanje su bila uključena 44 
 bolesnika i 27 bolesnica, ukupno njih 71, s akutnom femoralnom i poplitealnom DVT dijagnosticiranom Dopplerovom 
 ultrasonografijom tijekom sedam godina (2011.-2017.) i 142 ispitanika (88 muškaraca i 54 žena) izjednačenih po dobi i 
spolu te s dijagnozom venske insuficijencije postavljenom u istom razdoblju kao kontrolna skupina. Potrebni podaci za sve 
ispitanike dobiveni su iz njihovih bolničkih zapisa, uključujući kliničke i demografske karakteristike i parametre KKS. Uče-
stalost hipertenzije, šećerne bolesti, kronične opstruktivne plućne bolesti, kroničnog bubrežnog zatajenja i koronarne arterij-
ske bolesti bila je viša u skupini s DVT u usporedbi sa skupinom bez DVT (p<0,05). Vrijednosti hemoglobina i limfoctia bile 
su niže, a širina distribucije eritrocita, neutrofil, omjer neutrofila i limfocita te omjer trombocita i limfocita bili su viši u 
skupini s DVT u usporedbi sa skupinom bez DVT (p<0,05). Nije bilo značajne razlike među skupinama u vrijednostima 
srednjeg korpuskularnog volumena, trombocita, srednjeg volumena trombocita, omjera srednjeg volumena trombocita i širi-
ne distribucije trombocita (p>0,05). Hipertenzija, hemoglobin, omjer neutrofila i limfocita te omjer trombocita i limfocita 
pokazali su se kao neovisni čimbenici rizika za DVT. Utvrdili smo da su hipertenzija, anemija, omjer neutrofila i limfocita te 
omjer trombocita i limfocita neovisni čimbenici rizika za DVT. Naročito bi se omjer neutrofila i limfocita te hemoglobin 
mogli rabiti kao novi, jeftini i pouzdani dijagnostički alati za DVT.
Ključne riječi: Hipertenzija; Anemija; Omjer trombocita i limfocita; Omjer neutrofila i limfocita; Duboka venska tromboza
